Chemotherapy is given to all patients prior to BMT. Chemotherapy is often paired
with radiation in conditioning, and a specific plan such as a roadmap will be
provided to you that tell when the drugs are given. The goal for all conditioning
is destruction of the marrow (dropping the WBC to less than 0.1), immune system,
and cancer cells before transplant.
Chemotherapy are drugs which have been studied carefully and determined to
have benefit in destroying cancer cells, though often at the expense of having
side effects on the body. Chemotherapy drugs can be given several ways: by mouth,
by injections in a vein (IV), by injection into the muscle (IM, or a "shot),
under the skin (sub Q), and by spinal tap (IT). These anti-cancer drugs are
given at specific times to optimally kill the cancer cells. It can be expected
that some normal cells will also be damaged. Normal cells which replace themselves
rapidly, such as those of hair, mouth, intestines, and bone marrow, are most
often affected by drug treatment. This normal cell damage is one of the "side
effects" of chemotherapy. The physician must maintain a balance in favor of
killing most cancer cells and doing the least harm to normal cells.
The physician will discuss the treatment plan for your child with you. He/she
will answer any questions you may have about the treatment and the possible
side effects. The side effects may vary from child-to-child. (This is also true
of radiation therapy). The physician can give you the general trends that have
been observed in other children.
The following is a list of the chemotherapy drugs that may be given prior to
bone marrow transplant. The actual days the chemotherapy is given may differ
depending on the protocol your child is on.
VP-16
VP-16 is a chemotherapeutic agent which is given as an IV infusion. The
dose determines the length of infusion, but this can vary from 1 hour - 8 hours.
The major side effect is a rapid drop in blood pressure, and therefore, your
child will require frequent blood pressure monitoring throughout the infusion.
Generally, there is no nausea with this drug. Other side effects include diarrhea,
mouth sores, alopecia (hair loss) and GI bleeds.
Ara-c
Ara-c is a chemotherapeutic medication given IT (in the spinal fluid) and
IV in therapy. The IT infusion will be a procedure done by the physician or
physician assistant. A spinal needle is inserted by the medical staff and the
chemo is slowly pushed in. This is done to prevent central nervous system (CNS)
relapse.
For the IV infusion, Ara-c is usually given over three hours. Side effects
caused by Ara-c include nausea and vomiting, mouth sores, GI bleeding, hair
loss and dry eyes. Special eye drops are given to prevent the side effects of
dry eyes.
Cytoxan
Cytoxan is a chemotherapeutic medication that is usually given as a one
hour infusion. Cytoxan has the potential for causing cardiac problems, so a
baseline EKG is ordered before the first dose. If problems are discovered, further
EKGs will be ordered. Also, before the first dose of cytoxan, a Foley catheter
may need to be inserted to ensure good urine output and minimize the risk of
getting hemorrhagic cystitis (bleeding in the bladder), a major side effect
of this drug.
Medications such as B & O suppositories and pyridium can be given to patients
who develop bladder spasms with the Foley catheter. If there are no problems
with blood in the urine, the Foley will be removed 24 hours after the last dose
of Cytoxan. Other side effects of Cytoxan include nausea and vomiting, hair
loss, GI bleeding, mouth ulcers, and infertility.
Busulfan
Busulfan is an oral chemotherapeutic medication. This is given in the form
of small, white pills. If a patient cannot take the pills by mouth, the pills
can be put into capsules or they can be crushed and mixed with water and given
by a nasogastric tube. Busulfan is usually given every six hours for 16 doses.
Busulfan can cause seizures and sometimes patients will need to take dilantin,
an anti-seizure medication, while they are getting busulfan to prevent seizures
from occurring. Because of this seizure potential, dilantin (an anti-seizure
medication) will be ordered before the first busulfan dose. If the patient has
a history of seizures, seizure precautions such as padded side rails will be
used. Other side effects include lung injury (fibrosis), GI bleeds, and leaky
capillary syndrome.
Thiotepa
Thiotepa is a chemotherapy medication given IV over three hours. Thiotepa
may cause nausea, vomiting, skin irritation, mucositis and headaches.
Thiotepa is released through the skin and may cause skin irritation (especially
through the groin, armpit area and neck). For this reason, patients receiving
thiotepa must take three baths each day beginning with the first dose of thiotepa
and for 48 hours after the last dose. Your child must take one shower or tub
bath and the other two may be sponge baths. The sponge bath should be with water
only. Hibiclens should be included with the shower/bath.
Do not use creams or lotions on the skin during the time the thiotepa is given.
Avoid tape on the skin. Do one central line dressing change each day thiotepa
is given.
Melphalan
Melphalan is a chemotherapy medication that may be given prior to transplantation.
Melphalan is given IV over a short period of time (20-30 minutes). Melphalan
may cause nausea, vomiting diarrhea, and severe mucositis with painful mouth
sores. Melphalan may also cause liver damage.
Methotrexate
Methotrexate is a chemotherapy agent usually given IV over four hours. Leucovorin
is given following high dose methotrexate to lessen some of the side effects
of methotrexate, such as mouth and intestinal sores.
IV fluids are given following the administration of methotrexate and continue
for 3-4 days. Blood samples are drawn to check the level and clearance of methotrexate.
Urine output is closely monitored. The rate of the IV fluid may have to be increased
to maintain urine output. The acidity of the urine is also checked and additional
medication (sodium bicarbonate) may need to be given.
Low doses of methotrexate may also be given as part of a protocol to prevent
graft-versus-host disease. These low doses rarely cause problems, but if the
patient already has severe mucositis, methotrexate doses may be decreased or
deleted.
Carboplatin
Carboplatin is a chemotherapy medication usually given IV over two hours,
continuously over 24 hours.
Carboplatin may cause nausea and vomiting. Additional side effects include
hearing loss, decreased kidney function, loss of electrolytes (sodium, magnesium,
potassium and calcium) and decreased liver function. An allergic reaction may
occur, but this is very rare.
Title
Page
|